| Bioactivity | TBAJ-5307 is a broad spectrum anti-non-tuberculous mycobacteria inhibitor that can target the FO-domain of the engine and preventing rotation and proton-translocation. TBAJ-5307 inhibits non-tuberculous mycobacteria in vitro and in vivo[1]. |
| Name | TBAJ-5307 |
| CAS | 2332831-92-0 |
| Formula | C30H35BrN4O6 |
| Molar Mass | 627.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ragunathan P, et, al. High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against non-tuberculous mycobacteria in vitro and in vivo. J Biol Chem. 2024 Jan 2:105618. |
TBAJ-5307
CAS: 2332831-92-0 F: C30H35BrN4O6 W: 627.53
TBAJ-5307 is a broad spectrum anti-non-tuberculous mycobacteria inhibitor that can target the FO-domain of the engine an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.